COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Turkish Version of Mini-BESTest, Validity and Reliability for Adult Participants With Sensoriomotor Impairments

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03839381
Recruitment Status : Not yet recruiting
First Posted : February 15, 2019
Last Update Posted : February 15, 2019
Sponsor:
Information provided by (Responsible Party):
Sema BÜĞÜŞAN ORUÇ, T.C. ORDU ÜNİVERSİTESİ

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The aim of this study is to present the Turkish version of miniBESTest which evaluates the reasons of balance deficit and postural control. Accordingly, a practice of validity and reliability on adult patients with sensoriomotor impairments will be performed by utilizing the Turkish version of miniBESTest in this study.

Condition or disease
Parkinson Disease Multiple Sclerosis Trauma, Brain

Detailed Description:

Physical therapists encounter postural control problems frequently. These problems require multifaceted assessment. Therefore, the treatment of postural control problems should be planned after a multifaceted assessment.

Balance Evaluation Systems Test (BESTest) comprises 27 items and evaluate all components of postural control. MiniBESTest is a shortened version of BESTest with 14 tasks. MiniBESTest still addresses almost all components of postural control and can be performed 15 min. MiniBESTest is one of the most common methods which practiced on adult patients.

The aim of this study is to present the Turkish version of miniBESTest which evaluates the reasons of balance deficit and postural control. Accordingly, a practice of validity and reliability on adult participants with sensoriomotor impairments will be performed by utilizing the Turkish version of miniBESTest in this study.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Turkish Version of Mini-BESTest- Balance Evaluation Systems Test: A Translation and Transcultural Adaptation Study Incorporating Validity and Reliability Analysis for Adult Participants With Sensoriomotor Impairments
Estimated Study Start Date : March 4, 2019
Estimated Primary Completion Date : November 29, 2019
Estimated Study Completion Date : December 4, 2019

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Mini BESTest [ Time Frame: 10-15 minutes. ]
    Mini-BESTest focuses on dynamic balance. It includes a total of 14 different tasks, each rated on a 3-level between 0 (severe postural control impairment) and 2 (no postural control impairment) with a maximal score of 28.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The study was planned participants who have sensoriomotor impairments were referred to the Ordu University Educational Research Hospital neurology clinic.
Criteria

Inclusion Criteria:

Clinical diagnosis of sensoriomotor impairment Able to walk with or without an assistive device (e.g. walker, cane, ankle-foot orthosis...) Ability to tolerate the balance tasks without fatigue.

Exclusion Criteria:

Severe cognitive or communication impairments Hemodynamic or clinical instability.

Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03839381


Contacts
Layout table for location contacts
Contact: Sema Büğüşan Oruç, M.Sc. +905059301510 semabugusan@gmail.com
Contact: Sevim Acaröz Candan, PhD +905071027447 fzt_acaroz@hotmail.com

Sponsors and Collaborators
T.C. ORDU ÜNİVERSİTESİ
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications:

Layout table for additonal information
Responsible Party: Sema BÜĞÜŞAN ORUÇ, PHD student, T.C. ORDU ÜNİVERSİTESİ
ClinicalTrials.gov Identifier: NCT03839381    
Other Study ID Numbers: ORDU345
First Posted: February 15, 2019    Key Record Dates
Last Update Posted: February 15, 2019
Last Verified: February 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Sema BÜĞÜŞAN ORUÇ, T.C. ORDU ÜNİVERSİTESİ:
mini BESTest
balance defisit
postural control
Sensoriomotor impairment
Additional relevant MeSH terms:
Layout table for MeSH terms
Parkinson Disease
Multiple Sclerosis
Brain Injuries, Traumatic
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases
 Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases
Brain Injuries
Craniocerebral Trauma
Trauma, Nervous System
Wounds and Injuries